Awards & Advancement

SynteractHCR hires Bill Pierce and Richard Paul

Thursday, April 4, 2013 08:00 AM

SynteractHCR, a full-service CRO, has hired two new senior executives to support the company's growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs.

More... »

Chiltern promotes Stuart McGuire and Jim Szymeczek

Thursday, March 28, 2013 08:00 AM

Chiltern International, a global contract CRO, has promoted Stuart McGuire to the position of vice president of global business development, and Jim Szymeczek to the position of vice president of global information technology and systems.

More... »

PPD appoints Jay Dixon as vice president, global quality and compliance

Tuesday, March 26, 2013 08:00 AM

Pharmaceutical Product Development (PPD), a global CRO, has appointed Jay Dixon as senior vice president, global quality and compliance. Dixon’s expertise will enhance PPD’s ability to deliver industry-leading drug development services and high-quality data across the full spectrum of the research and development life cycle.

More... »

Array BioPharma names Michael Needle as chief medical officer

Friday, March 22, 2013 11:14 AM

Array BioPharma, a biopharmaceutical company focused on targeted small molecule drugs to treat cancer, has appointed Michael N. Needle, M.D., as its chief medical officer. 

More... »

INC Research appoints James Taylor as vice president of clinical development

Tuesday, March 19, 2013 08:00 AM

INC Research, a therapeutically focused global CRO, has appointed James Taylor as vice president of clinical development.

More... »

New York Genome Center Announces Change in Executive Leadership

Monday, March 18, 2013 09:59 AM

Nancy J. Kelley, founding executive director of the New York Genome Center (NYGC), an independent, non-profit organization that leverages the collaborative resources of leading academic medical centers, research universities and commercial organizations, will depart from her position with NYGC. She will remain an advisor and a member of the board of directors.

More... »

Chimerix appoints Michael Rogers as chief development officer

Monday, March 18, 2013 09:40 AM

Chimerix, a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, has appointed Michael D. Rogers, Ph.D., as chief development officer.

More... »

Parexel CEO Rickenbach to receive MassBio’s Henri Termeer Innovative Leadership Award

Monday, March 11, 2013 02:35 PM

Josef von Rickenbach, chairman and CEO of Parexel International, a global bio/pharmaceutical services organization, will be honored for his commitment and contributions to the biotechnology industry, by the Massachusetts Biotechnology Council (MassBio), a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry.

More... »

Leukemia & Lymphoma Society expands chief policy, advocacy officer role

Friday, March 8, 2013 10:34 AM

The Leukemia & Lymphoma Society (LLS) has expanded the role of chief policy and advocacy officer Mark Velleca, M.D., Ph.D. Velleca, who has headed LLS' Office of Public Policy in Washington, D.C., since early 2012, will now oversee the newly integrated patient advocacy, policy and programs department.

More... »

Sitrof promotes Kivlehan to director of mobility and collaboration

Thursday, March 7, 2013 01:43 PM

Princeton, N.J.-based Sitrof Technologies, a developer of content management, process harmonization and compliance solutions for the life sciences industry, has promoted Thomas Kivlehan to director, mobility and collaboration.

More... »